#FORMAT=WebAnno TSV 3.3
#T_SP=webanno.custom.ConceptLayer|identifier


Text=The persuasion network is modulated by drug-use risk and predicts anti-drug message effectiveness Abstract While a persuasion network has been proposed, little is known about how network connections between brain regions contribute to attitude change.
1-1	0-3	The	_
1-2	4-14	persuasion	_
1-3	15-22	network	_
1-4	23-25	is	_
1-5	26-35	modulated	_
1-6	36-38	by	_
1-7	39-47	drug-use	_
1-8	48-52	risk	_
1-9	53-56	and	_
1-10	57-65	predicts	_
1-11	66-75	anti-drug	_
1-12	76-83	message	_
1-13	84-97	effectiveness	_
1-14	98-106	Abstract	_
1-15	107-112	While	_
1-16	113-114	a	_
1-17	115-125	persuasion	_
1-18	126-133	network	_
1-19	134-137	has	_
1-20	138-142	been	_
1-21	143-151	proposed	_
1-22	152-153	,	_
1-23	154-160	little	_
1-24	161-163	is	_
1-25	164-169	known	_
1-26	170-175	about	_
1-27	176-179	how	_
1-28	180-187	network	_
1-29	188-199	connections	_
1-30	200-207	between	_
1-31	208-213	brain	_
1-32	214-221	regions	_
1-33	222-232	contribute	_
1-34	233-235	to	_
1-35	236-244	attitude	_
1-36	245-251	change	_
1-37	252-253	.	_

Text=Two possible mechanisms have been advanced.
2-1	254-257	Two	_
2-2	258-266	possible	_
2-3	267-277	mechanisms	_
2-4	278-282	have	_
2-5	283-287	been	_
2-6	288-296	advanced	_
2-7	297-298	.	_

Text=One hypothesis predicts that attitude change results from increased connectivity between structures implicated in affective and executive processing in response to increases in argument strength.
3-1	299-302	One	_
3-2	303-313	hypothesis	_
3-3	314-322	predicts	_
3-4	323-327	that	_
3-5	328-336	attitude	_
3-6	337-343	change	_
3-7	344-351	results	_
3-8	352-356	from	_
3-9	357-366	increased	_
3-10	367-379	connectivity	_
3-11	380-387	between	_
3-12	388-398	structures	_
3-13	399-409	implicated	_
3-14	410-412	in	_
3-15	413-422	affective	_
3-16	423-426	and	_
3-17	427-436	executive	_
3-18	437-447	processing	_
3-19	448-450	in	_
3-20	451-459	response	_
3-21	460-462	to	_
3-22	463-472	increases	_
3-23	473-475	in	_
3-24	476-484	argument	_
3-25	485-493	strength	_
3-26	494-495	.	_

Text=A second functional perspective suggests that highly arousing messages reduce connectivity between structures implicated in the encoding of sensory information, which disrupts message processing and thereby inhibits attitude change.
4-1	496-497	A	_
4-2	498-504	second	_
4-3	505-515	functional	_
4-4	516-527	perspective	_
4-5	528-536	suggests	_
4-6	537-541	that	_
4-7	542-548	highly	_
4-8	549-557	arousing	_
4-9	558-566	messages	_
4-10	567-573	reduce	_
4-11	574-586	connectivity	_
4-12	587-594	between	_
4-13	595-605	structures	_
4-14	606-616	implicated	_
4-15	617-619	in	_
4-16	620-623	the	_
4-17	624-632	encoding	_
4-18	633-635	of	_
4-19	636-643	sensory	_
4-20	644-655	information	_
4-21	656-657	,	_
4-22	658-663	which	_
4-23	664-672	disrupts	_
4-24	673-680	message	_
4-25	681-691	processing	_
4-26	692-695	and	_
4-27	696-703	thereby	_
4-28	704-712	inhibits	_
4-29	713-721	attitude	_
4-30	722-728	change	_
4-31	729-730	.	_

Text=However, persuasion is a multi-determined construct that results from both message features and audience characteristics.
5-1	731-738	However	_
5-2	739-740	,	_
5-3	741-751	persuasion	_
5-4	752-754	is	_
5-5	755-756	a	_
5-6	757-773	multi-determined	_
5-7	774-783	construct	_
5-8	784-788	that	_
5-9	789-796	results	_
5-10	797-801	from	_
5-11	802-806	both	_
5-12	807-814	message	_
5-13	815-823	features	_
5-14	824-827	and	_
5-15	828-836	audience	_
5-16	837-852	characteristics	_
5-17	853-854	.	_

Text=Therefore, persuasive messages should lead to specific functional connectivity patterns among a priori defined structures within the persuasion network.
6-1	855-864	Therefore	_
6-2	865-866	,	_
6-3	867-877	persuasive	_
6-4	878-886	messages	_
6-5	887-893	should	_
6-6	894-898	lead	_
6-7	899-901	to	_
6-8	902-910	specific	_
6-9	911-921	functional	_
6-10	922-934	connectivity	_
6-11	935-943	patterns	_
6-12	944-949	among	_
6-13	950-951	a	_
6-14	952-958	priori	_
6-15	959-966	defined	_
6-16	967-977	structures	_
6-17	978-984	within	_
6-18	985-988	the	_
6-19	989-999	persuasion	_
6-20	1000-1007	network	_
6-21	1008-1009	.	_

Text=The present study exposed 28 subjects to anti-drug public service announcements where arousal, argument strength, and subject drug-use risk were systematically varied.
7-1	1010-1013	The	_
7-2	1014-1021	present	_
7-3	1022-1027	study	_
7-4	1028-1035	exposed	_
7-5	1036-1038	28	_
7-6	1039-1047	subjects	_
7-7	1048-1050	to	_
7-8	1051-1060	anti-drug	_
7-9	1061-1067	public	_
7-10	1068-1075	service	_
7-11	1076-1089	announcements	_
7-12	1090-1095	where	_
7-13	1096-1103	arousal	_
7-14	1104-1105	,	_
7-15	1106-1114	argument	_
7-16	1115-1123	strength	_
7-17	1124-1125	,	_
7-18	1126-1129	and	_
7-19	1130-1137	subject	_
7-20	1138-1146	drug-use	_
7-21	1147-1151	risk	_
7-22	1152-1156	were	_
7-23	1157-1171	systematically	_
7-24	1172-1178	varied	_
7-25	1179-1180	.	_

Text=Psychophysiological interaction analyses provide support for the affective-executive hypothesis but not for the encoding-disruption hypothesis.
8-1	1181-1200	Psychophysiological	_
8-2	1201-1212	interaction	_
8-3	1213-1221	analyses	_
8-4	1222-1229	provide	_
8-5	1230-1237	support	_
8-6	1238-1241	for	_
8-7	1242-1245	the	_
8-8	1246-1265	affective-executive	_
8-9	1266-1276	hypothesis	_
8-10	1277-1280	but	_
8-11	1281-1284	not	_
8-12	1285-1288	for	_
8-13	1289-1292	the	_
8-14	1293-1312	encoding-disruption	_
8-15	1313-1323	hypothesis	_
8-16	1324-1325	.	_

Text=Secondary analyses show that video-level connectivity patterns among structures within the persuasion network predict audience responses in independent samples (one college-aged, one nationally representative).
9-1	1326-1335	Secondary	_
9-2	1336-1344	analyses	_
9-3	1345-1349	show	_
9-4	1350-1354	that	_
9-5	1355-1366	video-level	_
9-6	1367-1379	connectivity	_
9-7	1380-1388	patterns	_
9-8	1389-1394	among	_
9-9	1395-1405	structures	_
9-10	1406-1412	within	_
9-11	1413-1416	the	_
9-12	1417-1427	persuasion	_
9-13	1428-1435	network	_
9-14	1436-1443	predict	_
9-15	1444-1452	audience	_
9-16	1453-1462	responses	_
9-17	1463-1465	in	_
9-18	1466-1477	independent	_
9-19	1478-1485	samples	_
9-20	1486-1487	(	_
9-21	1488-1491	one	_
9-22	1492-1504	college-aged	_
9-23	1505-1506	,	_
9-24	1507-1510	one	_
9-25	1511-1521	nationally	_
9-26	1522-1536	representative	_
9-27	1537-1538	)	_
9-28	1539-1540	.	_

Text=We propose that persuasion neuroscience research is best advanced by considering network-level effects while accounting for interactions between message features and target audience characteristics.
10-1	1541-1543	We	_
10-2	1544-1551	propose	_
10-3	1552-1556	that	_
10-4	1557-1567	persuasion	_
10-5	1568-1580	neuroscience	_
10-6	1581-1589	research	_
10-7	1590-1592	is	_
10-8	1593-1597	best	_
10-9	1598-1606	advanced	_
10-10	1607-1609	by	_
10-11	1610-1621	considering	_
10-12	1622-1635	network-level	_
10-13	1636-1643	effects	_
10-14	1644-1649	while	_
10-15	1650-1660	accounting	_
10-16	1661-1664	for	_
10-17	1665-1677	interactions	_
10-18	1678-1685	between	_
10-19	1686-1693	message	_
10-20	1694-1702	features	_
10-21	1703-1706	and	_
10-22	1707-1713	target	_
10-23	1714-1722	audience	_
10-24	1723-1738	characteristics	_
10-25	1739-1740	.	_

Text=Methods Previous reporting and general method The subjects, materials, measures, experimental procedures, functional magnetic resonance imaging (fMRI) scanner parameters, and pre-processing pipeline used in this study are reported by.
11-1	1741-1748	Methods	_
11-2	1749-1757	Previous	_
11-3	1758-1767	reporting	_
11-4	1768-1771	and	_
11-5	1772-1779	general	_
11-6	1780-1786	method	_
11-7	1787-1790	The	_
11-8	1791-1799	subjects	_
11-9	1800-1801	,	_
11-10	1802-1811	materials	_
11-11	1812-1813	,	_
11-12	1814-1822	measures	_
11-13	1823-1824	,	_
11-14	1825-1837	experimental	_
11-15	1838-1848	procedures	_
11-16	1849-1850	,	_
11-17	1851-1861	functional	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-18	1862-1870	magnetic	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-19	1871-1880	resonance	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-20	1881-1888	imaging	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-21	1889-1890	(	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-22	1891-1895	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-23	1896-1897	)	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
11-24	1898-1905	scanner	_
11-25	1906-1916	parameters	_
11-26	1917-1918	,	_
11-27	1919-1922	and	_
11-28	1923-1937	pre-processing	_
11-29	1938-1946	pipeline	_
11-30	1947-1951	used	_
11-31	1952-1954	in	_
11-32	1955-1959	this	_
11-33	1960-1965	study	_
11-34	1966-1969	are	_
11-35	1970-1978	reported	_
11-36	1979-1981	by	_
11-37	1982-1983	.	_

Text=Briefly, the imaging data reported herein were pre-processed using FEAT (fMRI Expert Analysis Tool v6.0) from the Oxford Center for Functional MRI of the Brain (FMRIB) Software Library (FSL v5.0) using a standard pipeline.
12-1	1984-1991	Briefly	_
12-2	1992-1993	,	_
12-3	1994-1997	the	_
12-4	1998-2005	imaging	_
12-5	2006-2010	data	_
12-6	2011-2019	reported	_
12-7	2020-2026	herein	_
12-8	2027-2031	were	_
12-9	2032-2045	pre-processed	_
12-10	2046-2051	using	_
12-11	2052-2056	FEAT	_
12-12	2057-2058	(	_
12-13	2059-2063	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
12-14	2064-2070	Expert	_
12-15	2071-2079	Analysis	_
12-16	2080-2084	Tool	_
12-17	2085-2089	v6.0	_
12-18	2090-2091	)	_
12-19	2092-2096	from	_
12-20	2097-2100	the	_
12-21	2101-2107	Oxford	_
12-22	2108-2114	Center	_
12-23	2115-2118	for	_
12-24	2119-2129	Functional	_
12-25	2130-2133	MRI	_
12-26	2134-2136	of	_
12-27	2137-2140	the	_
12-28	2141-2146	Brain	_
12-29	2147-2148	(	_
12-30	2149-2154	FMRIB	_
12-31	2155-2156	)	_
12-32	2157-2165	Software	_
12-33	2166-2173	Library	_
12-34	2174-2175	(	_
12-35	2176-2179	FSL	_
12-36	2180-2184	v5.0	_
12-37	2185-2186	)	_
12-38	2187-2192	using	_
12-39	2193-2194	a	_
12-40	2195-2203	standard	_
12-41	2204-2212	pipeline	_
12-42	2213-2214	.	_

Text=The study adopted a 2x2x2 mixed factorial design which manipulated AS (high/low) and MSV (high/low) as within-subjects factors and subject drug-use risk (high/low) as between-subjects factors.
13-1	2215-2218	The	_
13-2	2219-2224	study	_
13-3	2225-2232	adopted	_
13-4	2233-2234	a	_
13-5	2235-2240	2x2x2	_
13-6	2241-2246	mixed	_
13-7	2247-2256	factorial	_
13-8	2257-2263	design	_
13-9	2264-2269	which	_
13-10	2270-2281	manipulated	_
13-11	2282-2284	AS	_
13-12	2285-2286	(	_
13-13	2287-2295	high/low	_
13-14	2296-2297	)	_
13-15	2298-2301	and	_
13-16	2302-2305	MSV	_
13-17	2306-2307	(	_
13-18	2308-2316	high/low	_
13-19	2317-2318	)	_
13-20	2319-2321	as	_
13-21	2322-2337	within-subjects	_
13-22	2338-2345	factors	_
13-23	2346-2349	and	_
13-24	2350-2357	subject	_
13-25	2358-2366	drug-use	_
13-26	2367-2371	risk	_
13-27	2372-2373	(	_
13-28	2374-2382	high/low	_
13-29	2383-2384	)	_
13-30	2385-2387	as	_
13-31	2388-2404	between-subjects	_
13-32	2405-2412	factors	_
13-33	2413-2414	.	_

Text=A total of 28 subjects, split evenly among high/low drug-use risk (assessed using the risk for marijuana use scale), were exposed to 32 30-second anti-drug PSAs (drawn from the Annenberg School for Communication at the University of Pennsylvania antidrug PSA archive) and eight control conditions; four of which featured PSAs where the video and audio had been scrambled (thereby preserving luminosity, auditory levels, and low-level visual features such as cuts, but removing semantic meaning), and four that showed a black screen with no visual or auditory features.
14-1	2415-2416	A	_
14-2	2417-2422	total	_
14-3	2423-2425	of	_
14-4	2426-2428	28	_
14-5	2429-2437	subjects	_
14-6	2438-2439	,	_
14-7	2440-2445	split	_
14-8	2446-2452	evenly	_
14-9	2453-2458	among	_
14-10	2459-2467	high/low	_
14-11	2468-2476	drug-use	_
14-12	2477-2481	risk	_
14-13	2482-2483	(	_
14-14	2484-2492	assessed	_
14-15	2493-2498	using	_
14-16	2499-2502	the	_
14-17	2503-2507	risk	_
14-18	2508-2511	for	http://maven.renci.org/NeuroBridge/neurobridge#CenterForEpidemiologicStudiesDepressionScale
14-19	2512-2521	marijuana	_
14-20	2522-2525	use	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
14-21	2526-2531	scale	http://maven.renci.org/NeuroBridge/neurobridge#AlcoholUseScale
14-22	2532-2533	)	_
14-23	2534-2535	,	_
14-24	2536-2540	were	_
14-25	2541-2548	exposed	_
14-26	2549-2551	to	_
14-27	2552-2554	32	_
14-28	2555-2564	30-second	_
14-29	2565-2574	anti-drug	_
14-30	2575-2579	PSAs	_
14-31	2580-2581	(	_
14-32	2582-2587	drawn	_
14-33	2588-2592	from	_
14-34	2593-2596	the	_
14-35	2597-2606	Annenberg	_
14-36	2607-2613	School	_
14-37	2614-2617	for	_
14-38	2618-2631	Communication	_
14-39	2632-2634	at	_
14-40	2635-2638	the	_
14-41	2639-2649	University	_
14-42	2650-2652	of	_
14-43	2653-2665	Pennsylvania	_
14-44	2666-2674	antidrug	_
14-45	2675-2678	PSA	_
14-46	2679-2686	archive	_
14-47	2687-2688	)	_
14-48	2689-2692	and	_
14-49	2693-2698	eight	_
14-50	2699-2706	control	_
14-51	2707-2717	conditions	_
14-52	2718-2719	;	_
14-53	2720-2724	four	_
14-54	2725-2727	of	_
14-55	2728-2733	which	_
14-56	2734-2742	featured	_
14-57	2743-2747	PSAs	_
14-58	2748-2753	where	_
14-59	2754-2757	the	_
14-60	2758-2763	video	_
14-61	2764-2767	and	_
14-62	2768-2773	audio	_
14-63	2774-2777	had	_
14-64	2778-2782	been	_
14-65	2783-2792	scrambled	_
14-66	2793-2794	(	_
14-67	2795-2802	thereby	_
14-68	2803-2813	preserving	_
14-69	2814-2824	luminosity	_
14-70	2825-2826	,	_
14-71	2827-2835	auditory	_
14-72	2836-2842	levels	_
14-73	2843-2844	,	_
14-74	2845-2848	and	_
14-75	2849-2858	low-level	_
14-76	2859-2865	visual	_
14-77	2866-2874	features	_
14-78	2875-2879	such	_
14-79	2880-2882	as	_
14-80	2883-2887	cuts	_
14-81	2888-2889	,	_
14-82	2890-2893	but	_
14-83	2894-2902	removing	_
14-84	2903-2911	semantic	_
14-85	2912-2919	meaning	_
14-86	2920-2921	)	_
14-87	2922-2923	,	_
14-88	2924-2927	and	_
14-89	2928-2932	four	_
14-90	2933-2937	that	_
14-91	2938-2944	showed	_
14-92	2945-2946	a	_
14-93	2947-2952	black	_
14-94	2953-2959	screen	_
14-95	2960-2964	with	_
14-96	2965-2967	no	_
14-97	2968-2974	visual	_
14-98	2975-2977	or	_
14-99	2978-2986	auditory	_
14-100	2987-2995	features	_
14-101	2996-2997	.	_

Text=PSAs and control conditions were split evenly between two runs in a counterbalanced order.
15-1	2998-3002	PSAs	_
15-2	3003-3006	and	_
15-3	3007-3014	control	_
15-4	3015-3025	conditions	_
15-5	3026-3030	were	_
15-6	3031-3036	split	_
15-7	3037-3043	evenly	_
15-8	3044-3051	between	_
15-9	3052-3055	two	_
15-10	3056-3060	runs	_
15-11	3061-3063	in	_
15-12	3064-3065	a	_
15-13	3066-3081	counterbalanced	_
15-14	3082-3087	order	_
15-15	3088-3089	.	_

Text=Subjects in the fMRI sample (henceforth referred to as MRIS) were drawn from the undergraduate research pool at University of California, Santa Barbara M (s.d.
16-1	3090-3098	Subjects	_
16-2	3099-3101	in	_
16-3	3102-3105	the	_
16-4	3106-3110	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
16-5	3111-3117	sample	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalMagneticResonanceImaging
16-6	3118-3119	(	_
16-7	3120-3130	henceforth	_
16-8	3131-3139	referred	_
16-9	3140-3142	to	_
16-10	3143-3145	as	_
16-11	3146-3150	MRIS	http://maven.renci.org/NeuroBridge/neurobridge#LowRisk
16-12	3151-3152	)	_
16-13	3153-3157	were	_
16-14	3158-3163	drawn	_
16-15	3164-3168	from	_
16-16	3169-3172	the	_
16-17	3173-3186	undergraduate	_
16-18	3187-3195	research	_
16-19	3196-3200	pool	_
16-20	3201-3203	at	_
16-21	3204-3214	University	_
16-22	3215-3217	of	_
16-23	3218-3228	California	_
16-24	3229-3230	,	_
16-25	3231-3236	Santa	_
16-26	3237-3244	Barbara	_
16-27	3245-3246	M	_
16-28	3247-3248	(	_
16-29	3249-3252	s.d	_
16-30	3253-3254	.	_

Text=) age = 20.3 (1.5).
17-1	3255-3256	)	_
17-2	3257-3260	age	_
17-3	3261-3262	=	_
17-4	3263-3267	20.3	_
17-5	3268-3269	(	_
17-6	3270-3273	1.5	_
17-7	3274-3275	)	_
17-8	3276-3277	.	_

Text=Subjects did not show any contraindication to fMRI scanning.
18-1	3278-3286	Subjects	_
18-2	3287-3290	did	_
18-3	3291-3294	not	_
18-4	3295-3299	show	_
18-5	3300-3303	any	_
18-6	3304-3320	contraindication	_
18-7	3321-3323	to	_
18-8	3324-3328	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
18-9	3329-3337	scanning	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
18-10	3338-3339	.	_

Text=All procedures conformed to the Declaration of Helsinki and were approved by the University ’ s Institutional Research Board.
19-1	3340-3343	All	_
19-2	3344-3354	procedures	_
19-3	3355-3364	conformed	_
19-4	3365-3367	to	_
19-5	3368-3371	the	_
19-6	3372-3383	Declaration	_
19-7	3384-3386	of	_
19-8	3387-3395	Helsinki	_
19-9	3396-3399	and	_
19-10	3400-3404	were	_
19-11	3405-3413	approved	_
19-12	3414-3416	by	_
19-13	3417-3420	the	_
19-14	3421-3431	University	_
19-15	3432-3433	’	_
19-16	3434-3435	s	_
19-17	3436-3449	Institutional	_
19-18	3450-3458	Research	_
19-19	3459-3464	Board	_
19-20	3465-3466	.	_

Text=Subjects watched each PSA while undergoing fMRI scanning.
20-1	3467-3475	Subjects	_
20-2	3476-3483	watched	_
20-3	3484-3488	each	_
20-4	3489-3492	PSA	_
20-5	3493-3498	while	_
20-6	3499-3509	undergoing	_
20-7	3510-3514	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
20-8	3515-3523	scanning	http://maven.renci.org/NeuroBridge/neurobridge#FunctionalImagingProtocol
20-9	3524-3525	.	_

Text=Participants provided a continuous response measure (CRM; not reported in this manuscript) of message convincingness (not at all convincing—very convincing) during the scanning session.
21-1	3526-3538	Participants	_
21-2	3539-3547	provided	_
21-3	3548-3549	a	_
21-4	3550-3560	continuous	_
21-5	3561-3569	response	_
21-6	3570-3577	measure	_
21-7	3578-3579	(	_
21-8	3580-3583	CRM	_
21-9	3584-3585	;	_
21-10	3586-3589	not	_
21-11	3590-3598	reported	_
21-12	3599-3601	in	_
21-13	3602-3606	this	_
21-14	3607-3617	manuscript	_
21-15	3618-3619	)	_
21-16	3620-3622	of	_
21-17	3623-3630	message	_
21-18	3631-3645	convincingness	_
21-19	3646-3647	(	_
21-20	3648-3651	not	_
21-21	3652-3654	at	_
21-22	3655-3658	all	_
21-23	3659-3674	convincing—very	_
21-24	3675-3685	convincing	_
21-25	3686-3687	)	_
21-26	3688-3694	during	_
21-27	3695-3698	the	_
21-28	3699-3707	scanning	_
21-29	3708-3715	session	_
21-30	3716-3717	.	_

Text=After the fMRI scan was complete, subjects were then exposed to the PSAs for a second time in a session that took place outside of the scanner.
22-1	3718-3723	After	_
22-2	3724-3727	the	_
22-3	3728-3732	fMRI	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
22-4	3733-3737	scan	http://maven.renci.org/NeuroBridge/neurobridge#RestingStateImaging
22-5	3738-3741	was	_
22-6	3742-3750	complete	_
22-7	3751-3752	,	_
22-8	3753-3761	subjects	_
22-9	3762-3766	were	_
22-10	3767-3771	then	_
22-11	3772-3779	exposed	_
22-12	3780-3782	to	_
22-13	3783-3786	the	_
22-14	3787-3791	PSAs	_
22-15	3792-3795	for	_
22-16	3796-3797	a	_
22-17	3798-3804	second	_
22-18	3805-3809	time	_
22-19	3810-3812	in	_
22-20	3813-3814	a	_
22-21	3815-3822	session	_
22-22	3823-3827	that	_
22-23	3828-3832	took	_
22-24	3833-3838	place	_
22-25	3839-3846	outside	_
22-26	3847-3849	of	_
22-27	3850-3853	the	_
22-28	3854-3861	scanner	_
22-29	3862-3863	.	_

Text=Self-report measures were collected during this session.
23-1	3864-3875	Self-report	_
23-2	3876-3884	measures	_
23-3	3885-3889	were	_
23-4	3890-3899	collected	_
23-5	3900-3906	during	_
23-6	3907-3911	this	_
23-7	3912-3919	session	_
23-8	3920-3921	.	_

Text=Subjects rated each PSA on perceived argument strength (pAS) and perceived message sensation value (pMSV).
24-1	3922-3930	Subjects	_
24-2	3931-3936	rated	_
24-3	3937-3941	each	_
24-4	3942-3945	PSA	_
24-5	3946-3948	on	_
24-6	3949-3958	perceived	_
24-7	3959-3967	argument	_
24-8	3968-3976	strength	_
24-9	3977-3978	(	_
24-10	3979-3982	pAS	_
24-11	3983-3984	)	_
24-12	3985-3988	and	_
24-13	3989-3998	perceived	_
24-14	3999-4006	message	_
24-15	4007-4016	sensation	_
24-16	4017-4022	value	_
24-17	4023-4024	(	_
24-18	4025-4029	pMSV	_
24-19	4030-4031	)	_
24-20	4032-4033	.	_

Text=Self-reported ratings of message effectiveness were evaluated using the perceived message effectiveness (PME) scale, which has been shown to correlate highly with actual PSA effectiveness and behavior change (Dillard et al.,).
25-1	4034-4047	Self-reported	_
25-2	4048-4055	ratings	_
25-3	4056-4058	of	_
25-4	4059-4066	message	_
25-5	4067-4080	effectiveness	_
25-6	4081-4085	were	_
25-7	4086-4095	evaluated	_
25-8	4096-4101	using	_
25-9	4102-4105	the	_
25-10	4106-4115	perceived	_
25-11	4116-4123	message	_
25-12	4124-4137	effectiveness	_
25-13	4138-4139	(	_
25-14	4140-4143	PME	_
25-15	4144-4145	)	http://maven.renci.org/NeuroBridge/neurobridge#Thing
25-16	4146-4151	scale	_
25-17	4152-4153	,	_
25-18	4154-4159	which	_
25-19	4160-4163	has	_
25-20	4164-4168	been	_
25-21	4169-4174	shown	_
25-22	4175-4177	to	_
25-23	4178-4187	correlate	_
25-24	4188-4194	highly	_
25-25	4195-4199	with	_
25-26	4200-4206	actual	_
25-27	4207-4210	PSA	_
25-28	4211-4224	effectiveness	_
25-29	4225-4228	and	_
25-30	4229-4237	behavior	_
25-31	4238-4244	change	_
25-32	4245-4246	(	_
25-33	4247-4254	Dillard	_
25-34	4255-4257	et	_
25-35	4258-4261	al.	_
25-36	4262-4263	,	_
25-37	4264-4265	)	_
25-38	4266-4267	.	_

Text=These PME ratings were drawn from two independent studies where subjects rated PME for each PSA.
26-1	4268-4273	These	_
26-2	4274-4277	PME	_
26-3	4278-4285	ratings	_
26-4	4286-4290	were	_
26-5	4291-4296	drawn	_
26-6	4297-4301	from	_
26-7	4302-4305	two	_
26-8	4306-4317	independent	_
26-9	4318-4325	studies	_
26-10	4326-4331	where	_
26-11	4332-4340	subjects	_
26-12	4341-4346	rated	_
26-13	4347-4350	PME	_
26-14	4351-4354	for	_
26-15	4355-4359	each	_
26-16	4360-4363	PSA	_
26-17	4364-4365	.	_

Text=The first sample (henceforth referred to as IS1) was among 599 college students M (s.d.
27-1	4366-4369	The	_
27-2	4370-4375	first	_
27-3	4376-4382	sample	_
27-4	4383-4384	(	_
27-5	4385-4395	henceforth	_
27-6	4396-4404	referred	_
27-7	4405-4407	to	_
27-8	4408-4410	as	_
27-9	4411-4414	IS1	_
27-10	4415-4416	)	_
27-11	4417-4420	was	_
27-12	4421-4426	among	_
27-13	4427-4430	599	_
27-14	4431-4438	college	_
27-15	4439-4447	students	_
27-16	4448-4449	M	_
27-17	4450-4451	(	_
27-18	4452-4455	s.d	_
27-19	4456-4457	.	_

Text=) age = 19.55 (2.12), 73.8% female.
28-1	4458-4459	)	_
28-2	4460-4463	age	_
28-3	4464-4465	=	_
28-4	4466-4471	19.55	_
28-5	4472-4473	(	_
28-6	4474-4478	2.12	_
28-7	4479-4480	)	_
28-8	4481-4482	,	_
28-9	4483-4487	73.8	_
28-10	4488-4489	%	_
28-11	4490-4496	female	_
28-12	4497-4498	.	_

Text=The second sample (IS2) was nationally representative of adolescents in the United States.
29-1	4499-4502	The	_
29-2	4503-4509	second	_
29-3	4510-4516	sample	_
29-4	4517-4518	(	_
29-5	4519-4522	IS2	_
29-6	4523-4524	)	_
29-7	4525-4528	was	_
29-8	4529-4539	nationally	_
29-9	4540-4554	representative	_
29-10	4555-4557	of	_
29-11	4558-4569	adolescents	_
29-12	4570-4572	in	_
29-13	4573-4576	the	_
29-14	4577-4583	United	_
29-15	4584-4590	States	_
29-16	4591-4592	.	_

Text=This sample (n = 601, Mage = 15.30, range 12–18) was balanced across males and females.
30-1	4593-4597	This	_
30-2	4598-4604	sample	_
30-3	4605-4606	(	_
30-4	4607-4608	n	_
30-5	4609-4610	=	_
30-6	4611-4614	601	_
30-7	4615-4616	,	_
30-8	4617-4621	Mage	_
30-9	4622-4623	=	_
30-10	4624-4629	15.30	_
30-11	4630-4631	,	_
30-12	4632-4637	range	_
30-13	4638-4643	12–18	_
30-14	4644-4645	)	_
30-15	4646-4649	was	_
30-16	4650-4658	balanced	_
30-17	4659-4665	across	_
30-18	4666-4671	males	_
30-19	4672-4675	and	_
30-20	4676-4683	females	_
30-21	4684-4685	.	_

Text=PPI analysis Whole-brain functional connectivity patterns for a set of structures in the persuasion network were evaluated using a series of PPI analyses.
31-1	4686-4689	PPI	_
31-2	4690-4698	analysis	_
31-3	4699-4710	Whole-brain	_
31-4	4711-4721	functional	_
31-5	4722-4734	connectivity	_
31-6	4735-4743	patterns	_
31-7	4744-4747	for	_
31-8	4748-4749	a	_
31-9	4750-4753	set	_
31-10	4754-4756	of	_
31-11	4757-4767	structures	_
31-12	4768-4770	in	_
31-13	4771-4774	the	_
31-14	4775-4785	persuasion	_
31-15	4786-4793	network	_
31-16	4794-4798	were	_
31-17	4799-4808	evaluated	_
31-18	4809-4814	using	_
31-19	4815-4816	a	_
31-20	4817-4823	series	_
31-21	4824-4826	of	_
31-22	4827-4830	PPI	_
31-23	4831-4839	analyses	_
31-24	4840-4841	.	_

Text=As discussed above, the seed ROIs used in this study were selected a priori based on the empirical literature.
32-1	4842-4844	As	_
32-2	4845-4854	discussed	_
32-3	4855-4860	above	_
32-4	4861-4862	,	_
32-5	4863-4866	the	_
32-6	4867-4871	seed	_
32-7	4872-4876	ROIs	_
32-8	4877-4881	used	_
32-9	4882-4884	in	_
32-10	4885-4889	this	_
32-11	4890-4895	study	_
32-12	4896-4900	were	_
32-13	4901-4909	selected	_
32-14	4910-4911	a	_
32-15	4912-4918	priori	_
32-16	4919-4924	based	_
32-17	4925-4927	on	_
32-18	4928-4931	the	_
32-19	4932-4941	empirical	_
32-20	4942-4952	literature	_
32-21	4953-4954	.	_

Text=Seed ROIs were constructed in FSL by drawing a binary 5 mm sphere (in MNI152 space) around coordinates previously reported in the literature and included the medial prefrontal cortex (MPFC, −4, 56, −4), middle frontal and superior termporal gyri (MFG, 38, 30, 34; STG, 56, 4, −18), IFG (−46, 28, 12), and inferior lateral occipital cortex (iLOC, −32, −70, −16).
33-1	4955-4959	Seed	_
33-2	4960-4964	ROIs	_
33-3	4965-4969	were	_
33-4	4970-4981	constructed	_
33-5	4982-4984	in	_
33-6	4985-4988	FSL	_
33-7	4989-4991	by	_
33-8	4992-4999	drawing	_
33-9	5000-5001	a	_
33-10	5002-5008	binary	_
33-11	5009-5010	5	_
33-12	5011-5013	mm	_
33-13	5014-5020	sphere	_
33-14	5021-5022	(	_
33-15	5023-5025	in	_
33-16	5026-5032	MNI152	_
33-17	5033-5038	space	_
33-18	5039-5040	)	_
33-19	5041-5047	around	_
33-20	5048-5059	coordinates	_
33-21	5060-5070	previously	_
33-22	5071-5079	reported	_
33-23	5080-5082	in	_
33-24	5083-5086	the	_
33-25	5087-5097	literature	_
33-26	5098-5101	and	_
33-27	5102-5110	included	_
33-28	5111-5114	the	_
33-29	5115-5121	medial	_
33-30	5122-5132	prefrontal	_
33-31	5133-5139	cortex	_
33-32	5140-5141	(	_
33-33	5142-5146	MPFC	_
33-34	5147-5148	,	_
33-35	5149-5151	−4	_
33-36	5152-5153	,	_
33-37	5154-5156	56	_
33-38	5157-5158	,	_
33-39	5159-5161	−4	_
33-40	5162-5163	)	_
33-41	5164-5165	,	_
33-42	5166-5172	middle	_
33-43	5173-5180	frontal	_
33-44	5181-5184	and	_
33-45	5185-5193	superior	_
33-46	5194-5203	termporal	_
33-47	5204-5208	gyri	_
33-48	5209-5210	(	_
33-49	5211-5214	MFG	_
33-50	5215-5216	,	_
33-51	5217-5219	38	_
33-52	5220-5221	,	_
33-53	5222-5224	30	_
33-54	5225-5226	,	_
33-55	5227-5229	34	_
33-56	5230-5231	;	_
33-57	5232-5235	STG	_
33-58	5236-5237	,	_
33-59	5238-5240	56	_
33-60	5241-5242	,	_
33-61	5243-5244	4	_
33-62	5245-5246	,	_
33-63	5247-5250	−18	_
33-64	5251-5252	)	_
33-65	5253-5254	,	_
33-66	5255-5258	IFG	_
33-67	5259-5260	(	_
33-68	5261-5264	−46	_
33-69	5265-5266	,	_
33-70	5267-5269	28	_
33-71	5270-5271	,	_
33-72	5272-5274	12	_
33-73	5275-5276	)	_
33-74	5277-5278	,	_
33-75	5279-5282	and	_
33-76	5283-5291	inferior	_
33-77	5292-5299	lateral	_
33-78	5300-5309	occipital	_
33-79	5310-5316	cortex	_
33-80	5317-5318	(	_
33-81	5319-5323	iLOC	_
33-82	5324-5325	,	_
33-83	5326-5329	−32	_
33-84	5330-5331	,	_
33-85	5332-5335	−70	_
33-86	5336-5337	,	_
33-87	5338-5341	−16	_
33-88	5342-5343	)	_
33-89	5344-5345	.	_

Text=Time series data (PHYS) were extracted from filtered functional data for each subject for each run within each seed ROI by taking the arithmetic mean of all voxels within the corresponding binary mask.
34-1	5346-5350	Time	_
34-2	5351-5357	series	_
34-3	5358-5362	data	_
34-4	5363-5364	(	_
34-5	5365-5369	PHYS	_
34-6	5370-5371	)	_
34-7	5372-5376	were	_
34-8	5377-5386	extracted	_
34-9	5387-5391	from	_
34-10	5392-5400	filtered	_
34-11	5401-5411	functional	_
34-12	5412-5416	data	_
34-13	5417-5420	for	_
34-14	5421-5425	each	_
34-15	5426-5433	subject	_
34-16	5434-5437	for	_
34-17	5438-5442	each	_
34-18	5443-5446	run	_
34-19	5447-5453	within	_
34-20	5454-5458	each	_
34-21	5459-5463	seed	_
34-22	5464-5467	ROI	_
34-23	5468-5470	by	_
34-24	5471-5477	taking	_
34-25	5478-5481	the	_
34-26	5482-5492	arithmetic	_
34-27	5493-5497	mean	_
34-28	5498-5500	of	_
34-29	5501-5504	all	_
34-30	5505-5511	voxels	_
34-31	5512-5518	within	_
34-32	5519-5522	the	_
34-33	5523-5536	corresponding	_
34-34	5537-5543	binary	_
34-35	5544-5548	mask	_
34-36	5549-5550	.	_

Text=First-level PPI general linear models (GLMs) were then fit separately using each seed ROI.
35-1	5551-5562	First-level	_
35-2	5563-5566	PPI	_
35-3	5567-5574	general	_
35-4	5575-5581	linear	_
35-5	5582-5588	models	_
35-6	5589-5590	(	_
35-7	5591-5595	GLMs	_
35-8	5596-5597	)	_
35-9	5598-5602	were	_
35-10	5603-5607	then	_
35-11	5608-5611	fit	_
35-12	5612-5622	separately	_
35-13	5623-5628	using	_
35-14	5629-5633	each	_
35-15	5634-5638	seed	_
35-16	5639-5642	ROI	_
35-17	5643-5644	.	_

Text=Following established guidelines, each first-level GLM included explanatory variables (EVs) that encoded experimental conditions (i.e.
36-1	5645-5654	Following	_
36-2	5655-5666	established	_
36-3	5667-5677	guidelines	_
36-4	5678-5679	,	_
36-5	5680-5684	each	_
36-6	5685-5696	first-level	_
36-7	5697-5700	GLM	_
36-8	5701-5709	included	_
36-9	5710-5721	explanatory	_
36-10	5722-5731	variables	_
36-11	5732-5733	(	_
36-12	5734-5737	EVs	_
36-13	5738-5739	)	_
36-14	5740-5744	that	_
36-15	5745-5752	encoded	_
36-16	5753-5765	experimental	_
36-17	5766-5776	conditions	_
36-18	5777-5778	(	_
36-19	5779-5782	i.e	_
36-20	5783-5784	.	_

Text=MSV High> MSV Low, AS High> AS Low), control conditions (C1 = scrambled, C2 = black screen), a PHYS EV, and two- and three-way condition by PHYS interaction terms (equation 1).
37-1	5785-5788	MSV	_
37-2	5789-5793	High	_
37-3	5794-5795	>	_
37-4	5796-5799	MSV	_
37-5	5800-5803	Low	_
37-6	5804-5805	,	_
37-7	5806-5808	AS	_
37-8	5809-5813	High	_
37-9	5814-5815	>	_
37-10	5816-5818	AS	_
37-11	5819-5822	Low	_
37-12	5823-5824	)	_
37-13	5825-5826	,	_
37-14	5827-5834	control	_
37-15	5835-5845	conditions	_
37-16	5846-5847	(	_
37-17	5848-5850	C1	_
37-18	5851-5852	=	_
37-19	5853-5862	scrambled	_
37-20	5863-5864	,	_
37-21	5865-5867	C2	_
37-22	5868-5869	=	_
37-23	5870-5875	black	_
37-24	5876-5882	screen	_
37-25	5883-5884	)	_
37-26	5885-5886	,	_
37-27	5887-5888	a	_
37-28	5889-5893	PHYS	_
37-29	5894-5896	EV	_
37-30	5897-5898	,	_
37-31	5899-5902	and	_
37-32	5903-5907	two-	_
37-33	5908-5911	and	_
37-34	5912-5921	three-way	_
37-35	5922-5931	condition	_
37-36	5932-5934	by	_
37-37	5935-5939	PHYS	_
37-38	5940-5951	interaction	_
37-39	5952-5957	terms	_
37-40	5958-5959	(	_
37-41	5960-5968	equation	_
37-42	5969-5970	1	_
37-43	5971-5972	)	_
37-44	5973-5974	.	_

Text=Following a hybrid generalized PPI approach (gPPI), contrasts were constructed between interaction EV coefficients (e.g.
38-1	5975-5984	Following	_
38-2	5985-5986	a	_
38-3	5987-5993	hybrid	_
38-4	5994-6005	generalized	_
38-5	6006-6009	PPI	_
38-6	6010-6018	approach	_
38-7	6019-6020	(	_
38-8	6021-6025	gPPI	_
38-9	6026-6027	)	_
38-10	6028-6029	,	_
38-11	6030-6039	contrasts	_
38-12	6040-6044	were	_
38-13	6045-6056	constructed	_
38-14	6057-6064	between	_
38-15	6065-6076	interaction	_
38-16	6077-6079	EV	_
38-17	6080-6092	coefficients	_
38-18	6093-6094	(	_
38-19	6095-6098	e.g	_
38-20	6099-6100	.	_

Text=AS × PHYS> C1 × PHYS).
39-1	6101-6103	AS	_
39-2	6104-6105	×	_
39-3	6106-6110	PHYS	_
39-4	6111-6112	>	_
39-5	6113-6115	C1	_
39-6	6116-6117	×	_
39-7	6118-6122	PHYS	_
39-8	6123-6124	)	_
39-9	6125-6126	.	_

Text=Importantly, while the full model was estimated, we deliberately do not consider the MSV × AS × PHYS> C1 × PHYS contrast.
40-1	6127-6138	Importantly	_
40-2	6139-6140	,	_
40-3	6141-6146	while	_
40-4	6147-6150	the	_
40-5	6151-6155	full	_
40-6	6156-6161	model	_
40-7	6162-6165	was	_
40-8	6166-6175	estimated	_
40-9	6176-6177	,	_
40-10	6178-6180	we	_
40-11	6181-6193	deliberately	_
40-12	6194-6196	do	_
40-13	6197-6200	not	_
40-14	6201-6209	consider	_
40-15	6210-6213	the	_
40-16	6214-6217	MSV	_
40-17	6218-6219	×	_
40-18	6220-6222	AS	_
40-19	6223-6224	×	_
40-20	6225-6229	PHYS	_
40-21	6230-6231	>	_
40-22	6232-6234	C1	_
40-23	6235-6236	×	_
40-24	6237-6241	PHYS	_
40-25	6242-6250	contrast	_
40-26	6251-6252	.	_

Text=The reason is that the sign of a three-way interaction does not have the same straightforward interpretation as a two-way interaction (where a positive sign indicates an increase and a negative sign a decrease in connectivity).
41-1	6253-6256	The	_
41-2	6257-6263	reason	_
41-3	6264-6266	is	_
41-4	6267-6271	that	_
41-5	6272-6275	the	_
41-6	6276-6280	sign	_
41-7	6281-6283	of	_
41-8	6284-6285	a	_
41-9	6286-6295	three-way	_
41-10	6296-6307	interaction	_
41-11	6308-6312	does	_
41-12	6313-6316	not	_
41-13	6317-6321	have	_
41-14	6322-6325	the	_
41-15	6326-6330	same	_
41-16	6331-6346	straightforward	_
41-17	6347-6361	interpretation	_
41-18	6362-6364	as	_
41-19	6365-6366	a	_
41-20	6367-6374	two-way	_
41-21	6375-6386	interaction	_
41-22	6387-6388	(	_
41-23	6389-6394	where	_
41-24	6395-6396	a	_
41-25	6397-6405	positive	_
41-26	6406-6410	sign	_
41-27	6411-6420	indicates	_
41-28	6421-6423	an	_
41-29	6424-6432	increase	_
41-30	6433-6436	and	_
41-31	6437-6438	a	_
41-32	6439-6447	negative	_
41-33	6448-6452	sign	_
41-34	6453-6454	a	_
41-35	6455-6463	decrease	_
41-36	6464-6466	in	_
41-37	6467-6479	connectivity	_
41-38	6480-6481	)	_
41-39	6482-6483	.	_

Text=This renders any contrast of a three-way interaction EV coefficient nearly uninterpretable against a two-way interaction EV coefficient.
42-1	6484-6488	This	_
42-2	6489-6496	renders	_
42-3	6497-6500	any	_
42-4	6501-6509	contrast	_
42-5	6510-6512	of	_
42-6	6513-6514	a	_
42-7	6515-6524	three-way	_
42-8	6525-6536	interaction	_
42-9	6537-6539	EV	_
42-10	6540-6551	coefficient	_
42-11	6552-6558	nearly	_
42-12	6559-6574	uninterpretable	_
42-13	6575-6582	against	_
42-14	6583-6584	a	_
42-15	6585-6592	two-way	_
42-16	6593-6604	interaction	_
42-17	6605-6607	EV	_
42-18	6608-6619	coefficient	_
42-19	6620-6621	.	_

Text=Still, the analysis and results are appropriate given that we are replicating/extending existing hypotheses (i.e.
43-1	6622-6627	Still	_
43-2	6628-6629	,	_
43-3	6630-6633	the	_
43-4	6634-6642	analysis	_
43-5	6643-6646	and	_
43-6	6647-6654	results	_
43-7	6655-6658	are	_
43-8	6659-6670	appropriate	_
43-9	6671-6676	given	_
43-10	6677-6681	that	_
43-11	6682-6684	we	_
43-12	6685-6688	are	_
43-13	6689-6710	replicating/extending	_
43-14	6711-6719	existing	_
43-15	6720-6730	hypotheses	_
43-16	6731-6732	(	_
43-17	6733-6736	i.e	_
43-18	6737-6738	.	_

Text=affective-executive, encoding-disruption) and their analytical paradigms.
44-1	6739-6758	affective-executive	_
44-2	6759-6760	,	_
44-3	6761-6780	encoding-disruption	_
44-4	6781-6782	)	_
44-5	6783-6786	and	_
44-6	6787-6792	their	_
44-7	6793-6803	analytical	_
44-8	6804-6813	paradigms	_
44-9	6814-6815	.	_

Text=A second-level analysis then combined runs for each subject in a fixed effects model.
45-1	6816-6817	A	_
45-2	6818-6830	second-level	_
45-3	6831-6839	analysis	_
45-4	6840-6844	then	_
45-5	6845-6853	combined	_
45-6	6854-6858	runs	_
45-7	6859-6862	for	_
45-8	6863-6867	each	_
45-9	6868-6875	subject	_
45-10	6876-6878	in	_
45-11	6879-6880	a	_
45-12	6881-6886	fixed	_
45-13	6887-6894	effects	_
45-14	6895-6900	model	_
45-15	6901-6902	.	_

Text=Finally, the interaction terms were analyzed in a series of third-level mixed effects models (FLAME 1).
46-1	6903-6910	Finally	_
46-2	6911-6912	,	_
46-3	6913-6916	the	_
46-4	6917-6928	interaction	_
46-5	6929-6934	terms	_
46-6	6935-6939	were	_
46-7	6940-6948	analyzed	_
46-8	6949-6951	in	_
46-9	6952-6953	a	_
46-10	6954-6960	series	_
46-11	6961-6963	of	_
46-12	6964-6975	third-level	_
46-13	6976-6981	mixed	_
46-14	6982-6989	effects	_
46-15	6990-6996	models	_
46-16	6997-6998	(	_
46-17	6999-7004	FLAME	_
46-18	7005-7006	1	_
46-19	7007-7008	)	_
46-20	7009-7010	.	_

Text=Subject drug-use risk (high/low) was specified as two groups in FSL ’ s FEAT tool (which lets variance estimates differ between groups), and then encoded using indicator variables.
47-1	7011-7018	Subject	_
47-2	7019-7027	drug-use	_
47-3	7028-7032	risk	_
47-4	7033-7034	(	_
47-5	7035-7043	high/low	_
47-6	7044-7045	)	_
47-7	7046-7049	was	_
47-8	7050-7059	specified	_
47-9	7060-7062	as	_
47-10	7063-7066	two	_
47-11	7067-7073	groups	_
47-12	7074-7076	in	_
47-13	7077-7080	FSL	_
47-14	7081-7082	’	_
47-15	7083-7084	s	_
47-16	7085-7089	FEAT	_
47-17	7090-7094	tool	_
47-18	7095-7096	(	_
47-19	7097-7102	which	_
47-20	7103-7107	lets	_
47-21	7108-7116	variance	_
47-22	7117-7126	estimates	_
47-23	7127-7133	differ	_
47-24	7134-7141	between	_
47-25	7142-7148	groups	_
47-26	7149-7150	)	_
47-27	7151-7152	,	_
47-28	7153-7156	and	_
47-29	7157-7161	then	_
47-30	7162-7169	encoded	_
47-31	7170-7175	using	_
47-32	7176-7185	indicator	_
47-33	7186-7195	variables	_
47-34	7196-7197	.	_

Text=Contrasts at the third-level assessed mean functional connectivity by risk group, as well as in the high-risk> low-risk and low-risk> high-risk contrasts.
48-1	7198-7207	Contrasts	_
48-2	7208-7210	at	_
48-3	7211-7214	the	_
48-4	7215-7226	third-level	_
48-5	7227-7235	assessed	_
48-6	7236-7240	mean	_
48-7	7241-7251	functional	_
48-8	7252-7264	connectivity	_
48-9	7265-7267	by	_
48-10	7268-7272	risk	_
48-11	7273-7278	group	_
48-12	7279-7280	,	_
48-13	7281-7283	as	_
48-14	7284-7288	well	_
48-15	7289-7291	as	_
48-16	7292-7294	in	_
48-17	7295-7298	the	_
48-18	7299-7308	high-risk	_
48-19	7309-7310	>	_
48-20	7311-7319	low-risk	_
48-21	7320-7323	and	_
48-22	7324-7332	low-risk	_
48-23	7333-7334	>	_
48-24	7335-7344	high-risk	_
48-25	7345-7354	contrasts	_
48-26	7355-7356	.	_

Text=A cluster-based procedure was applied to correct for multiple comparisons with a cluster defining threshold of Z = 2.3 and a cluster extent threshold of P <.05.
49-1	7357-7358	A	_
49-2	7359-7372	cluster-based	_
49-3	7373-7382	procedure	_
49-4	7383-7386	was	_
49-5	7387-7394	applied	_
49-6	7395-7397	to	_
49-7	7398-7405	correct	_
49-8	7406-7409	for	_
49-9	7410-7418	multiple	_
49-10	7419-7430	comparisons	_
49-11	7431-7435	with	_
49-12	7436-7437	a	_
49-13	7438-7445	cluster	_
49-14	7446-7454	defining	_
49-15	7455-7464	threshold	_
49-16	7465-7467	of	_
49-17	7468-7469	Z	_
49-18	7470-7471	=	_
49-19	7472-7475	2.3	_
49-20	7476-7479	and	_
49-21	7480-7481	a	_
49-22	7482-7489	cluster	_
49-23	7490-7496	extent	_
49-24	7497-7506	threshold	_
49-25	7507-7509	of	_
49-26	7510-7511	P	_
49-27	7512-7513	<	_
49-28	7514-7517	.05	_
49-29	7518-7519	.	_

Text=All structural localizations were identified using FSL ’ s probabilistic atlases and cross referenced with the Neurosynth database.
50-1	7520-7523	All	_
50-2	7524-7534	structural	_
50-3	7535-7548	localizations	_
50-4	7549-7553	were	_
50-5	7554-7564	identified	_
50-6	7565-7570	using	_
50-7	7571-7574	FSL	_
50-8	7575-7576	’	_
50-9	7577-7578	s	_
50-10	7579-7592	probabilistic	_
50-11	7593-7600	atlases	_
50-12	7601-7604	and	_
50-13	7605-7610	cross	_
50-14	7611-7621	referenced	_
50-15	7622-7626	with	_
50-16	7627-7630	the	_
50-17	7631-7641	Neurosynth	_
50-18	7642-7650	database	_
50-19	7651-7652	.	_

Text=Network-as-predictor analysis The previous section described a classic PPI analysis where task-modulated neural activity in a seed ROI is fit to every other voxel in the brain.
51-1	7653-7673	Network-as-predictor	_
51-2	7674-7682	analysis	_
51-3	7683-7686	The	_
51-4	7687-7695	previous	_
51-5	7696-7703	section	_
51-6	7704-7713	described	_
51-7	7714-7715	a	_
51-8	7716-7723	classic	_
51-9	7724-7727	PPI	_
51-10	7728-7736	analysis	_
51-11	7737-7742	where	_
51-12	7743-7757	task-modulated	_
51-13	7758-7764	neural	_
51-14	7765-7773	activity	_
51-15	7774-7776	in	_
51-16	7777-7778	a	_
51-17	7779-7783	seed	_
51-18	7784-7787	ROI	_
51-19	7788-7790	is	_
51-20	7791-7794	fit	_
51-21	7795-7797	to	_
51-22	7798-7803	every	_
51-23	7804-7809	other	_
51-24	7810-7815	voxel	_
51-25	7816-7818	in	_
51-26	7819-7822	the	_
51-27	7823-7828	brain	_
51-28	7829-7830	.	_

Text=Our network-as-predictor analyses had different aims, and a different analytical approach.
52-1	7831-7834	Our	_
52-2	7835-7855	network-as-predictor	_
52-3	7856-7864	analyses	_
52-4	7865-7868	had	_
52-5	7869-7878	different	_
52-6	7879-7883	aims	_
52-7	7884-7885	,	_
52-8	7886-7889	and	_
52-9	7890-7891	a	_
52-10	7892-7901	different	_
52-11	7902-7912	analytical	_
52-12	7913-7921	approach	_
52-13	7922-7923	.	_

Text=Here, we wanted to identify network connectivity patterns specific to each PSA and the degree to which variation in these patterns was predictive of PME in two independent samples.
53-1	7924-7928	Here	_
53-2	7929-7930	,	_
53-3	7931-7933	we	_
53-4	7934-7940	wanted	_
53-5	7941-7943	to	_
53-6	7944-7952	identify	_
53-7	7953-7960	network	_
53-8	7961-7973	connectivity	_
53-9	7974-7982	patterns	_
53-10	7983-7991	specific	_
53-11	7992-7994	to	_
53-12	7995-7999	each	_
53-13	8000-8003	PSA	_
53-14	8004-8007	and	_
53-15	8008-8011	the	_
53-16	8012-8018	degree	_
53-17	8019-8021	to	_
53-18	8022-8027	which	_
53-19	8028-8037	variation	_
53-20	8038-8040	in	_
53-21	8041-8046	these	_
53-22	8047-8055	patterns	_
53-23	8056-8059	was	_
53-24	8060-8070	predictive	_
53-25	8071-8073	of	_
53-26	8074-8077	PME	_
53-27	8078-8080	in	_
53-28	8081-8084	two	_
53-29	8085-8096	independent	_
53-30	8097-8104	samples	_
53-31	8105-8106	.	_

Text=To do this, we modified the brain-as-predictor analytical paradigm.
54-1	8107-8109	To	_
54-2	8110-8112	do	_
54-3	8113-8117	this	_
54-4	8118-8119	,	_
54-5	8120-8122	we	_
54-6	8123-8131	modified	_
54-7	8132-8135	the	_
54-8	8136-8154	brain-as-predictor	_
54-9	8155-8165	analytical	_
54-10	8166-8174	paradigm	_
54-11	8175-8176	.	_

Text=Whereas earlier brain-as-predictor studies used signal change in seed ROIs for each video (e.g.)
55-1	8177-8184	Whereas	_
55-2	8185-8192	earlier	_
55-3	8193-8211	brain-as-predictor	_
55-4	8212-8219	studies	_
55-5	8220-8224	used	_
55-6	8225-8231	signal	_
55-7	8232-8238	change	_
55-8	8239-8241	in	_
55-9	8242-8246	seed	_
55-10	8247-8251	ROIs	_
55-11	8252-8255	for	_
55-12	8256-8260	each	_
55-13	8261-8266	video	_
55-14	8267-8268	(	_
55-15	8269-8272	e.g	_
55-16	8273-8274	.	_
55-17	8275-8276	)	_

Text=to predict message effectiveness in independent samples, we used connectivity parameter estimates (PEs) between seed and target ROIs.
56-1	8277-8279	to	_
56-2	8280-8287	predict	_
56-3	8288-8295	message	_
56-4	8296-8309	effectiveness	_
56-5	8310-8312	in	_
56-6	8313-8324	independent	_
56-7	8325-8332	samples	_
56-8	8333-8334	,	_
56-9	8335-8337	we	_
56-10	8338-8342	used	_
56-11	8343-8355	connectivity	_
56-12	8356-8365	parameter	_
56-13	8366-8375	estimates	_
56-14	8376-8377	(	_
56-15	8378-8381	PEs	_
56-16	8382-8383	)	_
56-17	8384-8391	between	_
56-18	8392-8396	seed	_
56-19	8397-8400	and	_
56-20	8401-8407	target	_
56-21	8408-8412	ROIs	_
56-22	8413-8414	.	_

Text=Our seed ROIs were the same as those reported above in the PPI Analysis section while target ROIs for the encoding-disruption and affective-executive hypotheses were selected based on previous empirical results and therefore represent connectivity patterns that have been reported in the literature.
57-1	8415-8418	Our	_
57-2	8419-8423	seed	_
57-3	8424-8428	ROIs	_
57-4	8429-8433	were	_
57-5	8434-8437	the	_
57-6	8438-8442	same	_
57-7	8443-8445	as	_
57-8	8446-8451	those	_
57-9	8452-8460	reported	_
57-10	8461-8466	above	_
57-11	8467-8469	in	_
57-12	8470-8473	the	_
57-13	8474-8477	PPI	_
57-14	8478-8486	Analysis	_
57-15	8487-8494	section	_
57-16	8495-8500	while	_
57-17	8501-8507	target	_
57-18	8508-8512	ROIs	_
57-19	8513-8516	for	_
57-20	8517-8520	the	_
57-21	8521-8540	encoding-disruption	_
57-22	8541-8544	and	_
57-23	8545-8564	affective-executive	_
57-24	8565-8575	hypotheses	_
57-25	8576-8580	were	_
57-26	8581-8589	selected	_
57-27	8590-8595	based	_
57-28	8596-8598	on	_
57-29	8599-8607	previous	_
57-30	8608-8617	empirical	_
57-31	8618-8625	results	_
57-32	8626-8629	and	_
57-33	8630-8639	therefore	_
57-34	8640-8649	represent	_
57-35	8650-8662	connectivity	_
57-36	8663-8671	patterns	_
57-37	8672-8676	that	_
57-38	8677-8681	have	_
57-39	8682-8686	been	_
57-40	8687-8695	reported	_
57-41	8696-8698	in	_
57-42	8699-8702	the	_
57-43	8703-8713	literature	_
57-44	8714-8715	.	_

Text=A full list of seeds and their corresponding target ROIs can be found in Table 1.
58-1	8716-8717	A	_
58-2	8718-8722	full	_
58-3	8723-8727	list	_
58-4	8728-8730	of	_
58-5	8731-8736	seeds	_
58-6	8737-8740	and	_
58-7	8741-8746	their	_
58-8	8747-8760	corresponding	_
58-9	8761-8767	target	_
58-10	8768-8772	ROIs	_
58-11	8773-8776	can	_
58-12	8777-8779	be	_
58-13	8780-8785	found	_
58-14	8786-8788	in	_
58-15	8789-8794	Table	_
58-16	8795-8796	1	_
58-17	8797-8798	.	_

Text=Said differently, this seed-target ROI-based analysis examined how each PSA video modulated functional connectivity among a-priori defined structures within the persuasion network (for subjects in the MRIS sample) and the extent to which this variation was predictive of PME-ratings for each PSA in two large independent samples (IS1, IS2).
59-1	8799-8803	Said	_
59-2	8804-8815	differently	_
59-3	8816-8817	,	_
59-4	8818-8822	this	_
59-5	8823-8834	seed-target	_
59-6	8835-8844	ROI-based	_
59-7	8845-8853	analysis	_
59-8	8854-8862	examined	_
59-9	8863-8866	how	_
59-10	8867-8871	each	_
59-11	8872-8875	PSA	_
59-12	8876-8881	video	_
59-13	8882-8891	modulated	_
59-14	8892-8902	functional	_
59-15	8903-8915	connectivity	_
59-16	8916-8921	among	_
59-17	8922-8930	a-priori	_
59-18	8931-8938	defined	_
59-19	8939-8949	structures	_
59-20	8950-8956	within	_
59-21	8957-8960	the	_
59-22	8961-8971	persuasion	_
59-23	8972-8979	network	_
59-24	8980-8981	(	_
59-25	8982-8985	for	_
59-26	8986-8994	subjects	_
59-27	8995-8997	in	_
59-28	8998-9001	the	_
59-29	9002-9006	MRIS	_
59-30	9007-9013	sample	_
59-31	9014-9015	)	_
59-32	9016-9019	and	_
59-33	9020-9023	the	_
59-34	9024-9030	extent	_
59-35	9031-9033	to	_
59-36	9034-9039	which	_
59-37	9040-9044	this	_
59-38	9045-9054	variation	_
59-39	9055-9058	was	_
59-40	9059-9069	predictive	_
59-41	9070-9072	of	_
59-42	9073-9084	PME-ratings	_
59-43	9085-9088	for	_
59-44	9089-9093	each	_
59-45	9094-9097	PSA	_
59-46	9098-9100	in	_
59-47	9101-9104	two	_
59-48	9105-9110	large	_
59-49	9111-9122	independent	_
59-50	9123-9130	samples	_
59-51	9131-9132	(	_
59-52	9133-9136	IS1	_
59-53	9137-9138	,	_
59-54	9139-9142	IS2	_
59-55	9143-9144	)	_
59-56	9145-9146	.	_

Text=To that end, a series of gPPI models were constructed for each of the seed ROIs defined above.
60-1	9147-9149	To	_
60-2	9150-9154	that	_
60-3	9155-9158	end	_
60-4	9159-9160	,	_
60-5	9161-9162	a	_
60-6	9163-9169	series	_
60-7	9170-9172	of	_
60-8	9173-9177	gPPI	_
60-9	9178-9184	models	_
60-10	9185-9189	were	_
60-11	9190-9201	constructed	_
60-12	9202-9205	for	_
60-13	9206-9210	each	_
60-14	9211-9213	of	_
60-15	9214-9217	the	_
60-16	9218-9222	seed	_
60-17	9223-9227	ROIs	_
60-18	9228-9235	defined	_
60-19	9236-9241	above	_
60-20	9242-9243	.	_

Text=The first-level models (one model for each subject for each run for each seed ROI) included EVs that encoded each PSA video and control condition (C1 = scrambled, C2 = black screen), a PHYS EV, and then interaction terms (Equation 2).
61-1	9244-9247	The	_
61-2	9248-9259	first-level	_
61-3	9260-9266	models	_
61-4	9267-9268	(	_
61-5	9269-9272	one	_
61-6	9273-9278	model	_
61-7	9279-9282	for	_
61-8	9283-9287	each	_
61-9	9288-9295	subject	_
61-10	9296-9299	for	_
61-11	9300-9304	each	_
61-12	9305-9308	run	_
61-13	9309-9312	for	_
61-14	9313-9317	each	_
61-15	9318-9322	seed	_
61-16	9323-9326	ROI	_
61-17	9327-9328	)	_
61-18	9329-9337	included	_
61-19	9338-9341	EVs	_
61-20	9342-9346	that	_
61-21	9347-9354	encoded	_
61-22	9355-9359	each	_
61-23	9360-9363	PSA	_
61-24	9364-9369	video	_
61-25	9370-9373	and	_
61-26	9374-9381	control	_
61-27	9382-9391	condition	_
61-28	9392-9393	(	_
61-29	9394-9396	C1	_
61-30	9397-9398	=	_
61-31	9399-9408	scrambled	_
61-32	9409-9410	,	_
61-33	9411-9413	C2	_
61-34	9414-9415	=	_
61-35	9416-9421	black	_
61-36	9422-9428	screen	_
61-37	9429-9430	)	_
61-38	9431-9432	,	_
61-39	9433-9434	a	_
61-40	9435-9439	PHYS	_
61-41	9440-9442	EV	_
61-42	9443-9444	,	_
61-43	9445-9448	and	_
61-44	9449-9453	then	_
61-45	9454-9465	interaction	_
61-46	9466-9471	terms	_
61-47	9472-9473	(	_
61-48	9474-9482	Equation	_
61-49	9483-9484	2	_
61-50	9485-9486	)	_
61-51	9487-9488	.	_

Text=Contrasts at the first-level followed a gPPI logic and were defined as: VideoN × PHYS> C1 × PHYS.
62-1	9489-9498	Contrasts	_
62-2	9499-9501	at	_
62-3	9502-9505	the	_
62-4	9506-9517	first-level	_
62-5	9518-9526	followed	_
62-6	9527-9528	a	_
62-7	9529-9533	gPPI	_
62-8	9534-9539	logic	_
62-9	9540-9543	and	_
62-10	9544-9548	were	_
62-11	9549-9556	defined	_
62-12	9557-9559	as	_
62-13	9560-9561	:	_
62-14	9562-9568	VideoN	_
62-15	9569-9570	×	_
62-16	9571-9575	PHYS	_
62-17	9576-9577	>	_
62-18	9578-9580	C1	_
62-19	9581-9582	×	_
62-20	9583-9587	PHYS	_
62-21	9588-9589	.	_

Text=These contrasts of parameter estimates were then carried forward into two fixed-effects second-level analyses (one analysis for each run).
63-1	9590-9595	These	_
63-2	9596-9605	contrasts	_
63-3	9606-9608	of	_
63-4	9609-9618	parameter	_
63-5	9619-9628	estimates	_
63-6	9629-9633	were	_
63-7	9634-9638	then	_
63-8	9639-9646	carried	_
63-9	9647-9654	forward	_
63-10	9655-9659	into	_
63-11	9660-9663	two	_
63-12	9664-9677	fixed-effects	_
63-13	9678-9690	second-level	_
63-14	9691-9699	analyses	_
63-15	9700-9701	(	_
63-16	9702-9705	one	_
63-17	9706-9714	analysis	_
63-18	9715-9718	for	_
63-19	9719-9723	each	_
63-20	9724-9727	run	_
63-21	9728-9729	)	_
63-22	9730-9731	.	_

Text=At the second-level, indicator variables encoded subject drug-use risk (high/low).
64-1	9732-9734	At	_
64-2	9735-9738	the	_
64-3	9739-9751	second-level	_
64-4	9752-9753	,	_
64-5	9754-9763	indicator	_
64-6	9764-9773	variables	_
64-7	9774-9781	encoded	_
64-8	9782-9789	subject	_
64-9	9790-9798	drug-use	_
64-10	9799-9803	risk	_
64-11	9804-9805	(	_
64-12	9806-9814	high/low	_
64-13	9815-9816	)	_
64-14	9817-9818	.	_

Text=Planned contrasts evaluated functional connectivity for each PSA by risk group.
65-1	9819-9826	Planned	_
65-2	9827-9836	contrasts	_
65-3	9837-9846	evaluated	_
65-4	9847-9857	functional	_
65-5	9858-9870	connectivity	_
65-6	9871-9874	for	_
65-7	9875-9879	each	_
65-8	9880-9883	PSA	_
65-9	9884-9886	by	_
65-10	9887-9891	risk	_
65-11	9892-9897	group	_
65-12	9898-9899	.	_

Text=A 5 mm binary spherical mask was drawn for each a-priori defined target ROI.
66-1	9900-9901	A	_
66-2	9902-9903	5	_
66-3	9904-9906	mm	_
66-4	9907-9913	binary	_
66-5	9914-9923	spherical	_
66-6	9924-9928	mask	_
66-7	9929-9932	was	_
66-8	9933-9938	drawn	_
66-9	9939-9942	for	_
66-10	9943-9947	each	_
66-11	9948-9956	a-priori	_
66-12	9957-9964	defined	_
66-13	9965-9971	target	_
66-14	9972-9975	ROI	_
66-15	9976-9977	.	_

Text=Finally, FSL ’ s Featquery tool was used to extract median functional connectivity parameter estimates (PEs) between seed and target ROIs for each PSA for each of the second-level contrasts.
67-1	9978-9985	Finally	_
67-2	9986-9987	,	_
67-3	9988-9991	FSL	_
67-4	9992-9993	’	_
67-5	9994-9995	s	_
67-6	9996-10005	Featquery	_
67-7	10006-10010	tool	_
67-8	10011-10014	was	_
67-9	10015-10019	used	_
67-10	10020-10022	to	_
67-11	10023-10030	extract	_
67-12	10031-10037	median	_
67-13	10038-10048	functional	_
67-14	10049-10061	connectivity	_
67-15	10062-10071	parameter	_
67-16	10072-10081	estimates	_
67-17	10082-10083	(	_
67-18	10084-10087	PEs	_
67-19	10088-10089	)	_
67-20	10090-10097	between	_
67-21	10098-10102	seed	_
67-22	10103-10106	and	_
67-23	10107-10113	target	_
67-24	10114-10118	ROIs	_
67-25	10119-10122	for	_
67-26	10123-10127	each	_
67-27	10128-10131	PSA	_
67-28	10132-10135	for	_
67-29	10136-10140	each	_
67-30	10141-10143	of	_
67-31	10144-10147	the	_
67-32	10148-10160	second-level	_
67-33	10161-10170	contrasts	_
67-34	10171-10172	.	_

Text=These parameter estimates represent the strength of functional connectivity between key structures in the persuasion network for each risk group, as modulated by each PSA.
68-1	10173-10178	These	_
68-2	10179-10188	parameter	_
68-3	10189-10198	estimates	_
68-4	10199-10208	represent	_
68-5	10209-10212	the	_
68-6	10213-10221	strength	_
68-7	10222-10224	of	_
68-8	10225-10235	functional	_
68-9	10236-10248	connectivity	_
68-10	10249-10256	between	_
68-11	10257-10260	key	_
68-12	10261-10271	structures	_
68-13	10272-10274	in	_
68-14	10275-10278	the	_
68-15	10279-10289	persuasion	_
68-16	10290-10297	network	_
68-17	10298-10301	for	_
68-18	10302-10306	each	_
68-19	10307-10311	risk	_
68-20	10312-10317	group	_
68-21	10318-10319	,	_
68-22	10320-10322	as	_
68-23	10323-10332	modulated	_
68-24	10333-10335	by	_
68-25	10336-10340	each	_
68-26	10341-10344	PSA	_
68-27	10345-10346	.	_

Text=We then computed a zero order correlation matrix to examine the relationship between PEs and PME ratings in our two independent samples for each risk group.
69-1	10347-10349	We	_
69-2	10350-10354	then	_
69-3	10355-10363	computed	_
69-4	10364-10365	a	_
69-5	10366-10370	zero	_
69-6	10371-10376	order	_
69-7	10377-10388	correlation	_
69-8	10389-10395	matrix	_
69-9	10396-10398	to	_
69-10	10399-10406	examine	_
69-11	10407-10410	the	_
69-12	10411-10423	relationship	_
69-13	10424-10431	between	_
69-14	10432-10435	PEs	_
69-15	10436-10439	and	_
69-16	10440-10443	PME	_
69-17	10444-10451	ratings	_
69-18	10452-10454	in	_
69-19	10455-10458	our	_
69-20	10459-10462	two	_
69-21	10463-10474	independent	_
69-22	10475-10482	samples	_
69-23	10483-10486	for	_
69-24	10487-10491	each	_
69-25	10492-10496	risk	_
69-26	10497-10502	group	_
69-27	10503-10504	.	_

Text=We considered PEs that were significantly correlated with out-of-sample PME ratings as promising candidates in our network-as-predictor regression models.
70-1	10505-10507	We	_
70-2	10508-10518	considered	_
70-3	10519-10522	PEs	_
70-4	10523-10527	that	_
70-5	10528-10532	were	_
70-6	10533-10546	significantly	_
70-7	10547-10557	correlated	_
70-8	10558-10562	with	_
70-9	10563-10576	out-of-sample	_
70-10	10577-10580	PME	_
70-11	10581-10588	ratings	_
70-12	10589-10591	as	_
70-13	10592-10601	promising	_
70-14	10602-10612	candidates	_
70-15	10613-10615	in	_
70-16	10616-10619	our	_
70-17	10620-10640	network-as-predictor	_
70-18	10641-10651	regression	_
70-19	10652-10658	models	_
70-20	10659-10660	.	_

Text=The actual prediction regression models followed the analytical logic established in with one notable change: instead of transforming all PEs and PME evaluations into ranks for each PSA and risk group, we used the original unranked continuous data in our prediction models (making sure that no outliers were present).
71-1	10661-10664	The	_
71-2	10665-10671	actual	_
71-3	10672-10682	prediction	_
71-4	10683-10693	regression	_
71-5	10694-10700	models	_
71-6	10701-10709	followed	_
71-7	10710-10713	the	_
71-8	10714-10724	analytical	_
71-9	10725-10730	logic	_
71-10	10731-10742	established	_
71-11	10743-10745	in	_
71-12	10746-10750	with	_
71-13	10751-10754	one	_
71-14	10755-10762	notable	_
71-15	10763-10769	change	_
71-16	10770-10771	:	_
71-17	10772-10779	instead	_
71-18	10780-10782	of	_
71-19	10783-10795	transforming	_
71-20	10796-10799	all	_
71-21	10800-10803	PEs	_
71-22	10804-10807	and	_
71-23	10808-10811	PME	_
71-24	10812-10823	evaluations	_
71-25	10824-10828	into	_
71-26	10829-10834	ranks	_
71-27	10835-10838	for	_
71-28	10839-10843	each	_
71-29	10844-10847	PSA	_
71-30	10848-10851	and	_
71-31	10852-10856	risk	_
71-32	10857-10862	group	_
71-33	10863-10864	,	_
71-34	10865-10867	we	_
71-35	10868-10872	used	_
71-36	10873-10876	the	_
71-37	10877-10885	original	_
71-38	10886-10894	unranked	_
71-39	10895-10905	continuous	_
71-40	10906-10910	data	_
71-41	10911-10913	in	_
71-42	10914-10917	our	_
71-43	10918-10928	prediction	_
71-44	10929-10935	models	_
71-45	10936-10937	(	_
71-46	10938-10944	making	_
71-47	10945-10949	sure	_
71-48	10950-10954	that	_
71-49	10955-10957	no	_
71-50	10958-10966	outliers	_
71-51	10967-10971	were	_
71-52	10972-10979	present	_
71-53	10980-10981	)	_
71-54	10982-10983	.	_

Text=Unranked data did not lead to any substantial differences (compared to ranked data) and in a few cases, our modified procedure was slightly more conservative (that is, it led to lower prediction accuracies).
72-1	10984-10992	Unranked	_
72-2	10993-10997	data	_
72-3	10998-11001	did	_
72-4	11002-11005	not	_
72-5	11006-11010	lead	_
72-6	11011-11013	to	_
72-7	11014-11017	any	_
72-8	11018-11029	substantial	_
72-9	11030-11041	differences	_
72-10	11042-11043	(	_
72-11	11044-11052	compared	_
72-12	11053-11055	to	_
72-13	11056-11062	ranked	_
72-14	11063-11067	data	_
72-15	11068-11069	)	_
72-16	11070-11073	and	_
72-17	11074-11076	in	_
72-18	11077-11078	a	_
72-19	11079-11082	few	_
72-20	11083-11088	cases	_
72-21	11089-11090	,	_
72-22	11091-11094	our	_
72-23	11095-11103	modified	_
72-24	11104-11113	procedure	_
72-25	11114-11117	was	_
72-26	11118-11126	slightly	_
72-27	11127-11131	more	_
72-28	11132-11144	conservative	_
72-29	11145-11146	(	_
72-30	11147-11151	that	_
72-31	11152-11154	is	_
72-32	11155-11156	,	_
72-33	11157-11159	it	_
72-34	11160-11163	led	_
72-35	11164-11166	to	_
72-36	11167-11172	lower	_
72-37	11173-11183	prediction	_
72-38	11184-11194	accuracies	_
72-39	11195-11196	)	_
72-40	11197-11198	.	_

Text=As in our network-as-predictor analysis employed a step-wise regression procedure.
73-1	11199-11201	As	_
73-2	11202-11204	in	_
73-3	11205-11208	our	_
73-4	11209-11229	network-as-predictor	_
73-5	11230-11238	analysis	_
73-6	11239-11247	employed	_
73-7	11248-11249	a	_
73-8	11250-11259	step-wise	_
73-9	11260-11270	regression	_
73-10	11271-11280	procedure	_
73-11	11281-11282	.	_

Text=In a first step we estimated baseline regression models which included the self-reported PSA evaluations in our MRIS sample that are known to be predictive from traditional persuasion theory (pMSV, pAS, and the pMSV × pAS interaction).
74-1	11283-11285	In	_
74-2	11286-11287	a	_
74-3	11288-11293	first	_
74-4	11294-11298	step	_
74-5	11299-11301	we	_
74-6	11302-11311	estimated	_
74-7	11312-11320	baseline	_
74-8	11321-11331	regression	_
74-9	11332-11338	models	_
74-10	11339-11344	which	_
74-11	11345-11353	included	_
74-12	11354-11357	the	_
74-13	11358-11371	self-reported	_
74-14	11372-11375	PSA	_
74-15	11376-11387	evaluations	_
74-16	11388-11390	in	_
74-17	11391-11394	our	_
74-18	11395-11399	MRIS	_
74-19	11400-11406	sample	_
74-20	11407-11411	that	_
74-21	11412-11415	are	_
74-22	11416-11421	known	_
74-23	11422-11424	to	_
74-24	11425-11427	be	_
74-25	11428-11438	predictive	_
74-26	11439-11443	from	_
74-27	11444-11455	traditional	_
74-28	11456-11466	persuasion	_
74-29	11467-11473	theory	_
74-30	11474-11475	(	_
74-31	11476-11480	pMSV	_
74-32	11481-11482	,	_
74-33	11483-11486	pAS	_
74-34	11487-11488	,	_
74-35	11489-11492	and	_
74-36	11493-11496	the	_
74-37	11497-11501	pMSV	_
74-38	11502-11503	×	_
74-39	11504-11507	pAS	_
74-40	11508-11519	interaction	_
74-41	11520-11521	)	_
74-42	11522-11523	.	_

Text=All self-report predictors were group mean centered to reduce bias in predictor coefficients due to the inherent multicollinearity between main- and interaction-effect predictors.
75-1	11524-11527	All	_
75-2	11528-11539	self-report	_
75-3	11540-11550	predictors	_
75-4	11551-11555	were	_
75-5	11556-11561	group	_
75-6	11562-11566	mean	_
75-7	11567-11575	centered	_
75-8	11576-11578	to	_
75-9	11579-11585	reduce	_
75-10	11586-11590	bias	_
75-11	11591-11593	in	_
75-12	11594-11603	predictor	_
75-13	11604-11616	coefficients	_
75-14	11617-11620	due	_
75-15	11621-11623	to	_
75-16	11624-11627	the	_
75-17	11628-11636	inherent	_
75-18	11637-11654	multicollinearity	_
75-19	11655-11662	between	_
75-20	11663-11668	main-	_
75-21	11669-11672	and	_
75-22	11673-11691	interaction-effect	_
75-23	11692-11702	predictors	_
75-24	11703-11704	.	_

Text=We then included the brain network PEs as predictors in a second step.
76-1	11705-11707	We	_
76-2	11708-11712	then	_
76-3	11713-11721	included	_
76-4	11722-11725	the	_
76-5	11726-11731	brain	_
76-6	11732-11739	network	_
76-7	11740-11743	PEs	_
76-8	11744-11746	as	_
76-9	11747-11757	predictors	_
76-10	11758-11760	in	_
76-11	11761-11762	a	_
76-12	11763-11769	second	_
76-13	11770-11774	step	_
76-14	11775-11776	.	_

Text=This procedure allowed us to identify the network connectivity PEs that increased PME prediction accuracy above and beyond self-reported PSA evaluations.
77-1	11777-11781	This	_
77-2	11782-11791	procedure	_
77-3	11792-11799	allowed	_
77-4	11800-11802	us	_
77-5	11803-11805	to	_
77-6	11806-11814	identify	_
77-7	11815-11818	the	_
77-8	11819-11826	network	_
77-9	11827-11839	connectivity	_
77-10	11840-11843	PEs	_
77-11	11844-11848	that	_
77-12	11849-11858	increased	_
77-13	11859-11862	PME	_
77-14	11863-11873	prediction	_
77-15	11874-11882	accuracy	_
77-16	11883-11888	above	_
77-17	11889-11892	and	_
77-18	11893-11899	beyond	_
77-19	11900-11913	self-reported	_
77-20	11914-11917	PSA	_
77-21	11918-11929	evaluations	_
77-22	11930-11931	.	_

